Several mechanisms lead to insulin resistance in OSA, including hypoxia, sleep fragmentation, sympathetic nervous system activation, dyslipidemia, oxidative stress, and inflammation [45,46,47]
The well-established GST-pulldown method (left)
The BPC-157 and TB-500 blend (available as a 10mg research blend) represents a complementary approach, pairing GH-driven anabolic signaling from sermorelin or tesamorelin with targeted tissue healing a protocol particularly studied in musculoskeletal repair research models
So the argument to be made is using the lowest GLP-1 dose possible to elicit gradual weight loss over time while optimizing diet, resistance exercise, etc
Salazar was NOP, and almost nothing happened there without his say-so